Cardiac performance during vasopressin infusion in postcardiotomy shock

Arginine-vasopressin (AVP) might be a potent vasopressor agent in catecholamine-resistant postcardiotomy shock. However, its use remains experimental because of considerations about deleterious effects on the heart. We report on the effects of continuous AVP-infusion on cardiac performance, biomarke...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Intensive care medicine 2002-06, Vol.28 (6), p.746-751
Hauptverfasser:	DÜNSER, M. W, MAYR, A. J, STALLINGER, A, ULMER, H, RITSCH, N, KNOTZER, H, PAJK, W, MUTZ, N. J, HASIBEDER, W. R
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged APACHE Arginine Vasopressin - therapeutic use Biological and medical sciences Cardiopulmonary Bypass Cardiotonic agents Cardiovascular system Drug toxicity and drugs side effects treatment Female Hemodynamics - drug effects Humans Male Medical sciences Multiple Organ Failure - classification Multiple Organ Failure - drug therapy Multiple Organ Failure - physiopathology Pharmacology. Drug treatments Postoperative Complications Retrospective Studies Shock - drug therapy Shock - etiology Toxicity: cardiovascular system Vasoconstrictor Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!